Manage Your Liver
Q:

World Hepatitis Day 2016 - Focus on long term protection after treatment to achieve a 65% reduction in deaths

World Hepatitis Day 2016 - Focus on long term protection after treatment to achieve a 65% reduction in deaths
A:

The World Health Organization’s strategy on viral hepatitis in 2015 estimated that there would be 1.4 million deaths from hepatitis-related diseases in 2016. The mortality rate is very high and the number of deaths is far greater than the sum of deaths from Malaria and HIV [1]. Therefore, one of the main targets of World Hepatitis Day 2016 is to reduce hepatitis-related deaths by 65% by 2030, through improving vaccination, preventing early-life infection and providing universal access to treatment.

 

A 65% reduction is not an easy target and in order to achieve this target by 2030, there is a key factor that cannot be neglected but was not mentioned above: post-treatment recovery and protection.

 

A recent study stated that even after successful eradication of hepatitis C virus and achieving sustained virologic response (SVR), the risk of hepatocellular carcinoma (HCC) or liver cancer remains [2]. Another research conducted by the University of Barcelona pointed out that after receiving treatment, some hepatitis C patients developed HCC and the progression was very fast. Research suspected that this was due to the immune system, and suggested that hepatitis C patients monitor their condition closely after treatment, especially those who had HCC or liver fibrosis previously[3].

 

These results show that the risk of serious liver diseases remains even after successful treatment. In addition, after eliminating the virus, the liver needs to rely on its self-repair ability to produce new liver cells so that normal liver function can resume. Therefore, enhancing liver recovery and protection is an integral part that should be added to the strategy. In order to reduce the number of deaths caused by hepatitis-related diseases by 65% effectively, post-treatment liver protection measures must be improved to ensure the liver’s longevity and lower the risk of death.

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
world hepatitis Dat 2016long term protectionafter careliver protectionYHK
Related Questions
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health. Multiple studies have demonstrated that the presence of an elevated ALT level is associated with increased liver-related mortality.   New normal ALT level issued The American College of Gastroenterology (ACG) recently issued a new Practice Guideline that aims to offer a framewor
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
Hit Questions
A:
Fatty liver is on the rise and it is quickly becoming one of the most worrying disease in developed countries, a condition that most Americans have never heard of and now experts say as many as one in three of us may be at risk. Fatty liver disease is a gradual killer which often shows no symptoms until it develops into a much server problem like: cirrhosis - a condition that could lead to liver cancer or death.   Douglas Denham is medical director at Clinical Trials
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health. Multiple studies have demonstrated that the presence of an elevated ALT level is associated with increased liver-related mortality.   New normal ALT level issued The American College of Gastroenterology (ACG) recently issued a new Practice Guideline that aims to offer a framewor
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
It’s almost yearend, have you achieved any health goals you wished for?  If you are still thinking about how to improve your liver health, this is your chance. We are now offering an exclusive promotion, enjoy 10% off on all orders!  Don’t miss this great chance to boost your liver health!   Special Promotion 10% OFF:  Period: 8th De
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us